Vaxcyte
Blood & Organ Banks · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
825 Industrial Rd Ste 300, San Carlos, C...Phone Number
(650) 837-0111Website
www.vaxcyte.comRevenue
-Stock Symbol
PCVXIndustry
About Vaxcyte
Vaxcyte Org Chart
Is Vaxcyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Vaxcyte is spiking on competitors!
Check if Vaxcyte has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vaxcyte recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Vaxcyte had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Vaxcyte has new funding data
Congratulate Masked Content for being promoted to Masked Content at Vaxcyte
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Vaxcyte, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Vaxcyte launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Vaxcyte
Compare insights from companies similar to Vaxcyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vaxcyte is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Vaxcyte is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Vaxcyte.
Vaxcyte financials insights
Gather financial insights about Vaxcyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$22M
Other Financing Round
$4M
Series B
$60M
Series C
$85M
Series D
$110M
Stock Offering
$100M
Share Placement
$750M
Vaxcyte Tech Stack
A closer look at the technologies used by Vaxcyte
Most Recent Scoops
Vaxcyte News & Media
Vaxcyte Has $2.5 Billion in Cash and a $605 Million Half-Year Loss. Here's How to Read Its CFO's Latest Insider Filing
Guggenhime surrendered shares to cover tax withholding on vesting RSUs, retaining about 164,000 shares valued at $10.12 million.A Vaxcyte Executive Just Cashed Options Struck at $5.35. Here's What Long-Term Investors Should Know
Wassil exercised options at a steep discount and surrendered shares for tax withholding, maintaining a 0.1% ownership stake following the transactions.Vaxcyte's CEO Parted With Shares for Taxes. Here's What Long-Term Investors Should Know About the Firm
The stock has surged 95% over the past year, and the CEO retains about 447,000 direct shares plus indirect holdings.The Next Year Will Define Vaxcyte’s (PCVX) Vaccine Gamble
On August 5, Vaxcyte (NASDAQ:PCVX) reported second-quarter results that read less like a snapshot of today and more like a countdown to a verdict. The clinical-stage vaccine maker has no product on the market yet, but its three late-stage trials for its lead pneumococcal candidate are now fully enrolled, with the first major readout due […]
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vaxcyte
Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The company is headquartered in San Carlos, California.... Read More
